Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 36 entries
Sorted by: Best Match Show Resources per page
Use of restriction fragment length polymorphism to identify Candida species, related to onychomycosis.

Advanced biomedical research

Mohammadi R, Badiee P, Badali H, Abastabar M, Safa AH, Hadipour M, Yazdani H, Heshmat F.
PMID: 26015921
Adv Biomed Res. 2015 May 11;4:95. doi: 10.4103/2277-9175.156659. eCollection 2015.

BACKGROUND: Onychomycosis is one of the most common clinical forms of fungal infections due to both filamentous fungi and yeasts. The genus of Candida is one of the most prominent causes of onychomycosis in all around the world. Although...

Cite
Mohammadi R, Badiee P, Badali H, et al. Use of restriction fragment length polymorphism to identify Candida species, related to onychomycosis. Adv Biomed Res. 2015;4:95doi: 10.4103/2277-9175.156659.
Mohammadi, R., Badiee, P., Badali, H., Abastabar, M., Safa, A. H., Hadipour, M., Yazdani, H., & Heshmat, F. (2015). Use of restriction fragment length polymorphism to identify Candida species, related to onychomycosis. Advanced biomedical research, 495. https://doi.org/10.4103/2277-9175.156659
Mohammadi, Rasoul, et al. "Use of restriction fragment length polymorphism to identify Candida species, related to onychomycosis." Advanced biomedical research vol. 4 (2015): 95. doi: https://doi.org/10.4103/2277-9175.156659
Mohammadi R, Badiee P, Badali H, Abastabar M, Safa AH, Hadipour M, Yazdani H, Heshmat F. Use of restriction fragment length polymorphism to identify Candida species, related to onychomycosis. Adv Biomed Res. 2015 May 11;4:95. doi: 10.4103/2277-9175.156659. eCollection 2015. PMID: 26015921; PMCID: PMC4434489.
Copy Download .nbib Format: NLM
[No title available]

Current medical mycology

Abastabar M, Shokohi T, Rouhi Kord R, Badali H, Hashemi SJ, Ghasemi Z, Ghojoghi A, Baghi N, Abdollahi M, Hosseinpoor S, Rahimi N, Seifi Z, Gholami S, Haghani I, Jabari MR, Pagheh A.
PMID: 28680998
Curr Med Mycol. 2015 Dec;1(4):7-12. doi: 10.18869/acadpub.cmm.1.4.7.

RESULTS: The MIC of econazole, itraconazole, miconazole, and fluconazole were within the range of 0.016-16, 0.032-16, 0.016-16, and 0.25-64 μg/ml, respectively. In general, econazole and miconazole were more active against CONCLUSION: The present study demonstrated that for

Cite
Abastabar M, Shokohi T, Rouhi Kord R, et al. . Curr Med Mycol. 2015;1(4):7-12doi: 10.18869/acadpub.cmm.1.4.7.
Abastabar, M., Shokohi, T., Rouhi Kord, R., Badali, H., Hashemi, S. J., Ghasemi, Z., Ghojoghi, A., Baghi, N., Abdollahi, M., Hosseinpoor, S., Rahimi, N., Seifi, Z., Gholami, S., Haghani, I., Jabari, M. R., & Pagheh, A. (2015). . Current medical mycology, 1(4), 7-12. https://doi.org/10.18869/acadpub.cmm.1.4.7
Abastabar, M, et al. "." Current medical mycology vol. 1,4 (2015): 7-12. doi: https://doi.org/10.18869/acadpub.cmm.1.4.7
Abastabar M, Shokohi T, Rouhi Kord R, Badali H, Hashemi SJ, Ghasemi Z, Ghojoghi A, Baghi N, Abdollahi M, Hosseinpoor S, Rahimi N, Seifi Z, Gholami S, Haghani I, Jabari MR, Pagheh A. . Curr Med Mycol. 2015 Dec;1(4):7-12. doi: 10.18869/acadpub.cmm.1.4.7. PMID: 28680998; PMCID: PMC5490275.
Copy Download .nbib Format: NLM
Identification of clinical dermatophyte isolates obtained from Iran by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Current medical mycology

Hedayati MT, Ansari S, Ahmadi B, Taghizadeh Armaki M, Shokohi T, Abastabar M, Er H, Özhak B, Öğünç D, Ilkit M, Seyedmousavi S.
PMID: 31321334
Curr Med Mycol. 2019 Jun;5(2):22-26. doi: 10.18502/cmm.5.2.1157.

BACKGROUND AND PURPOSE: Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is widely used to discriminate among pathogenic microorganisms in clinical laboratories. The aim of this study was to assess the utility of MALDI-TOF MS in the routine identification...

Cite
Hedayati MT, Ansari S, Ahmadi B, et al. Identification of clinical dermatophyte isolates obtained from Iran by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Curr Med Mycol. 2019;5(2):22-26doi: 10.18502/cmm.5.2.1157.
Hedayati, M. T., Ansari, S., Ahmadi, B., Taghizadeh Armaki, M., Shokohi, T., Abastabar, M., Er, H., Özhak, B., Öğünç, D., Ilkit, M., & Seyedmousavi, S. (2019). Identification of clinical dermatophyte isolates obtained from Iran by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Current medical mycology, 5(2), 22-26. https://doi.org/10.18502/cmm.5.2.1157
Hedayati, Mohammad Taghi, et al. "Identification of clinical dermatophyte isolates obtained from Iran by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry." Current medical mycology vol. 5,2 (2019): 22-26. doi: https://doi.org/10.18502/cmm.5.2.1157
Hedayati MT, Ansari S, Ahmadi B, Taghizadeh Armaki M, Shokohi T, Abastabar M, Er H, Özhak B, Öğünç D, Ilkit M, Seyedmousavi S. Identification of clinical dermatophyte isolates obtained from Iran by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Curr Med Mycol. 2019 Jun;5(2):22-26. doi: 10.18502/cmm.5.2.1157. PMID: 31321334; PMCID: PMC6626716.
Copy Download .nbib Format: NLM
Prosthetic valve endocarditis caused by multidrug-resistant .

Current medical mycology

Kermani F, Shokohi T, Abastabar M, Davoodi L, Ziabakhsh Tabari S, Jalalian R, Mehdipour S, Mirzakhani R.
PMID: 30619966
Curr Med Mycol. 2018 Sep;4(3):23-27. doi: 10.18502/cmm.4.3.171.

CASE REPORT: Herein, we reported a 70-year-old woman with the history of severe mitral stenosis and myelodysplasia syndrome. She underwent mitral valve replacement for two times. The blood cultures were positive, and phenotypic identification of the isolates at the...

Cite
Kermani F, Shokohi T, Abastabar M, et al. Prosthetic valve endocarditis caused by multidrug-resistant . Curr Med Mycol. 2018;4(3):23-27doi: 10.18502/cmm.4.3.171.
Kermani, F., Shokohi, T., Abastabar, M., Davoodi, L., Ziabakhsh Tabari, S., Jalalian, R., Mehdipour, S., & Mirzakhani, R. (2018). Prosthetic valve endocarditis caused by multidrug-resistant . Current medical mycology, 4(3), 23-27. https://doi.org/10.18502/cmm.4.3.171
Kermani, Firoozeh, et al. "Prosthetic valve endocarditis caused by multidrug-resistant ." Current medical mycology vol. 4,3 (2018): 23-27. doi: https://doi.org/10.18502/cmm.4.3.171
Kermani F, Shokohi T, Abastabar M, Davoodi L, Ziabakhsh Tabari S, Jalalian R, Mehdipour S, Mirzakhani R. Prosthetic valve endocarditis caused by multidrug-resistant . Curr Med Mycol. 2018 Sep;4(3):23-27. doi: 10.18502/cmm.4.3.171. PMID: 30619966; PMCID: PMC6315203.
Copy Download .nbib Format: NLM
First fluconazole-resistant .

Current medical mycology

Taghizadeh Armaki M, Mahdavi Omran S, Kiakojuri K, Khojasteh S, Jafarzadeh J, Tavakoli M, Badali H, Haghani I, Shokohi T, Taghi Hedayati M, Abastabar M.
PMID: 34553098
Curr Med Mycol. 2021 Mar;7(1):51-54. doi: 10.18502/cmm.7.1.6243.

CASE REPORT: This report aimed to describe the first fluconazole-resistant case of CONCLUSION: This was the second strain of

Cite
Taghizadeh Armaki M, Mahdavi Omran S, Kiakojuri K, et al. First fluconazole-resistant . Curr Med Mycol. 2021;7(1):51-54doi: 10.18502/cmm.7.1.6243.
Taghizadeh Armaki, M., Mahdavi Omran, S., Kiakojuri, K., Khojasteh, S., Jafarzadeh, J., Tavakoli, M., Badali, H., Haghani, I., Shokohi, T., Taghi Hedayati, M., & Abastabar, M. (2021). First fluconazole-resistant . Current medical mycology, 7(1), 51-54. https://doi.org/10.18502/cmm.7.1.6243
Taghizadeh Armaki, Mojtaba, et al. "First fluconazole-resistant ." Current medical mycology vol. 7,1 (2021): 51-54. doi: https://doi.org/10.18502/cmm.7.1.6243
Taghizadeh Armaki M, Mahdavi Omran S, Kiakojuri K, Khojasteh S, Jafarzadeh J, Tavakoli M, Badali H, Haghani I, Shokohi T, Taghi Hedayati M, Abastabar M. First fluconazole-resistant . Curr Med Mycol. 2021 Mar;7(1):51-54. doi: 10.18502/cmm.7.1.6243. PMID: 34553098; PMCID: PMC8443880.
Copy Download .nbib Format: NLM
Emergence of Terbinafine Resistant .

Infection and drug resistance

Taghipour S, Shamsizadeh F, Pchelin IM, Rezaei-Matehhkolaei A, Zarei Mahmoudabadi A, Valadan R, Ansari S, Katiraee F, Pakshir K, Zomorodian K, Abastabar M.
PMID: 32214830
Infect Drug Resist. 2020 Mar 13;13:845-850. doi: 10.2147/IDR.S246025. eCollection 2020.

METHODS: A total of 96 RESULTS: Luliconazole and efinaconazole showed the lowest MIC values against CONCLUSION: This study documented a step in the global spread of resistance mechanisms in

Cite
Taghipour S, Shamsizadeh F, Pchelin IM, et al. Emergence of Terbinafine Resistant . Infect Drug Resist. 2020;13:845-850doi: 10.2147/IDR.S246025.
Taghipour, S., Shamsizadeh, F., Pchelin, I. M., Rezaei-Matehhkolaei, A., Zarei Mahmoudabadi, A., Valadan, R., Ansari, S., Katiraee, F., Pakshir, K., Zomorodian, K., & Abastabar, M. (2020). Emergence of Terbinafine Resistant . Infection and drug resistance, 13845-850. https://doi.org/10.2147/IDR.S246025
Taghipour, Simin, et al. "Emergence of Terbinafine Resistant ." Infection and drug resistance vol. 13 (2020): 845-850. doi: https://doi.org/10.2147/IDR.S246025
Taghipour S, Shamsizadeh F, Pchelin IM, Rezaei-Matehhkolaei A, Zarei Mahmoudabadi A, Valadan R, Ansari S, Katiraee F, Pakshir K, Zomorodian K, Abastabar M. Emergence of Terbinafine Resistant . Infect Drug Resist. 2020 Mar 13;13:845-850. doi: 10.2147/IDR.S246025. eCollection 2020. PMID: 32214830; PMCID: PMC7078656.
Copy Download .nbib Format: NLM
A multi-centered study of .

Current medical mycology

Abastabar M, Mosayebi E, Shokohi T, Hedayati MT, Jabari Amiri MR, Seifi Z, Haghani I, Aliyali M, Saber S, Sheikholeslami MF.
PMID: 31850392
Curr Med Mycol. 2019 Sep;5(3):19-25. doi: 10.18502/cmm.5.3.1742.

MATERIALS AND METHODS: This study was conducted on 136 samples obtained from 136 patients with respiratory disorders referring to different hospitals in the capital and north of Iran during 2013-2015. The samples were collected using bronchoalveolar lavage (BAL; n=121)...

Cite
Abastabar M, Mosayebi E, Shokohi T, et al. A multi-centered study of . Curr Med Mycol. 2019;5(3):19-25doi: 10.18502/cmm.5.3.1742.
Abastabar, M., Mosayebi, E., Shokohi, T., Hedayati, M. T., Jabari Amiri, M. R., Seifi, Z., Haghani, I., Aliyali, M., Saber, S., & Sheikholeslami, M. F. (2019). A multi-centered study of . Current medical mycology, 5(3), 19-25. https://doi.org/10.18502/cmm.5.3.1742
Abastabar, Mahdi, et al. "A multi-centered study of ." Current medical mycology vol. 5,3 (2019): 19-25. doi: https://doi.org/10.18502/cmm.5.3.1742
Abastabar M, Mosayebi E, Shokohi T, Hedayati MT, Jabari Amiri MR, Seifi Z, Haghani I, Aliyali M, Saber S, Sheikholeslami MF. A multi-centered study of . Curr Med Mycol. 2019 Sep;5(3):19-25. doi: 10.18502/cmm.5.3.1742. PMID: 31850392; PMCID: PMC6910707.
Copy Download .nbib Format: NLM
The trend of incidence and burden of neurological disease in Iran between 1990 and 2017: Based on global burden of disease estimations.

Iranian journal of neurology

Abbastabar H, Bitarafan S, Harirchian MH.
PMID: 31749935
Iran J Neurol. 2019 Jul 06;18(3):134-142.

Neurological disease contributes significantly to morbidity and mortality in different ages and geographic areas around the world. The purpose of the current study was to investigate the incidence and disability-adjusted life years (DALYs) trend of neurological disease in Iran...

Cite
Abbastabar H, Bitarafan S, Harirchian MH. The trend of incidence and burden of neurological disease in Iran between 1990 and 2017: Based on global burden of disease estimations. Iran J Neurol. 2019;18(3):134-142
Abbastabar, H., Bitarafan, S., & Harirchian, M. H. (2019). The trend of incidence and burden of neurological disease in Iran between 1990 and 2017: Based on global burden of disease estimations. Iranian journal of neurology, 18(3), 134-142.
Abbastabar, Hedayat, et al. "The trend of incidence and burden of neurological disease in Iran between 1990 and 2017: Based on global burden of disease estimations." Iranian journal of neurology vol. 18,3 (2019): 134-142.
Abbastabar H, Bitarafan S, Harirchian MH. The trend of incidence and burden of neurological disease in Iran between 1990 and 2017: Based on global burden of disease estimations. Iran J Neurol. 2019 Jul 06;18(3):134-142. PMID: 31749935; PMCID: PMC6858595.
Copy Download .nbib Format: NLM
[No title available]

Iranian journal of parasitology

Gholami S, Jahandar H, Abastabar M, Pagheh A, Mobedi I, Sharbatkhori M.
PMID: 28096852
Iran J Parasitol. 2016 Apr-Jun;11(2):186-194.

RESULTS: Four different sequences were observed among the isolates. Two genotypes [G1 (66.7%) and G3 (33.3%)] were identified among the isolates. The G1 sequences indicated three sequence profiles. One profile (Maz1) had 100% homology with reference sequence (AN: KP339045)....

Cite
Gholami S, Jahandar H, Abastabar M, et al. . Iran J Parasitol. 2016;11(2):186-194
Gholami, S., Jahandar, H., Abastabar, M., Pagheh, A., Mobedi, I., & Sharbatkhori, M. (2016). . Iranian journal of parasitology, 11(2), 186-194.
Gholami, Shirzad, et al. "." Iranian journal of parasitology vol. 11,2 (2016): 186-194.
Gholami S, Jahandar H, Abastabar M, Pagheh A, Mobedi I, Sharbatkhori M. . Iran J Parasitol. 2016 Apr-Jun;11(2):186-194. PMID: 28096852; PMCID: PMC5236095.
Copy Download .nbib Format: NLM
Hyphal wall protein 1 gene: A potential marker for the identification of different .

Current medical mycology

Abastabar M, Hosseinpoor S, Hedayati MT, Shokohi T, Valadan R, Mirhendi H, Mohammadi R, Aghili SR, Rahimi N, Aslani N, Haghani I, Gholami S.
PMID: 28959789
Curr Med Mycol. 2016 Dec;2(4):1-8. doi: 10.18869/acadpub.cmm.2.4.1.

BACKGROUND AND PURPOSE: Hyphal wall protein 1 (MATERIALS AND METHODS: Initially, four specific primer pairs were designedRESULTS: According to the results, the specific amplified fragments of CONCLUSION: We found that

Cite
Abastabar M, Hosseinpoor S, Hedayati MT, et al. Hyphal wall protein 1 gene: A potential marker for the identification of different . Curr Med Mycol. 2016;2(4):1-8doi: 10.18869/acadpub.cmm.2.4.1.
Abastabar, M., Hosseinpoor, S., Hedayati, M. T., Shokohi, T., Valadan, R., Mirhendi, H., Mohammadi, R., Aghili, S. R., Rahimi, N., Aslani, N., Haghani, I., & Gholami, S. (2016). Hyphal wall protein 1 gene: A potential marker for the identification of different . Current medical mycology, 2(4), 1-8. https://doi.org/10.18869/acadpub.cmm.2.4.1
Abastabar, M, et al. "Hyphal wall protein 1 gene: A potential marker for the identification of different ." Current medical mycology vol. 2,4 (2016): 1-8. doi: https://doi.org/10.18869/acadpub.cmm.2.4.1
Abastabar M, Hosseinpoor S, Hedayati MT, Shokohi T, Valadan R, Mirhendi H, Mohammadi R, Aghili SR, Rahimi N, Aslani N, Haghani I, Gholami S. Hyphal wall protein 1 gene: A potential marker for the identification of different . Curr Med Mycol. 2016 Dec;2(4):1-8. doi: 10.18869/acadpub.cmm.2.4.1. PMID: 28959789; PMCID: PMC5611690.
Copy Download .nbib Format: NLM
lncRNA involvement in hepatocellular carcinoma metastasis and prognosis.

EXCLI journal

Abbastabar M, Sarfi M, Golestani A, Khalili E.
PMID: 30564069
EXCLI J. 2018 Sep 04;17:900-913. doi: 10.17179/excli2018-1541. eCollection 2018.

Eukaryotic lncRNAs are RNA molecules defined to be greater than 200 bp in length that are not translated to a protein and operate through several mechanisms, including participating in chromatin remodeling and methylation, influencing the integrity and stability of...

Cite
Abbastabar M, Sarfi M, Golestani A, et al. lncRNA involvement in hepatocellular carcinoma metastasis and prognosis. EXCLI J. 2018;17:900-913doi: 10.17179/excli2018-1541.
Abbastabar, M., Sarfi, M., Golestani, A., & Khalili, E. (2018). lncRNA involvement in hepatocellular carcinoma metastasis and prognosis. EXCLI journal, 17900-913. https://doi.org/10.17179/excli2018-1541
Abbastabar, Maryam, et al. "lncRNA involvement in hepatocellular carcinoma metastasis and prognosis." EXCLI journal vol. 17 (2018): 900-913. doi: https://doi.org/10.17179/excli2018-1541
Abbastabar M, Sarfi M, Golestani A, Khalili E. lncRNA involvement in hepatocellular carcinoma metastasis and prognosis. EXCLI J. 2018 Sep 04;17:900-913. doi: 10.17179/excli2018-1541. eCollection 2018. PMID: 30564069; PMCID: PMC6295623.
Copy Download .nbib Format: NLM
Molecular identification and antifungal susceptibility testing of .

Current medical mycology

Kermani F, Sadeghian M, Shokohi T, Hashemi S, Moslemi D, Davodian S, Abastabar M, Bandalizadeh Z, Faeli L, Seifi Z, Fami Zaghrami M, Haghani I.
PMID: 34553097
Curr Med Mycol. 2021 Mar;7(1):44-50. doi: 10.18502/cmm.7.1.6242.

BACKGROUND AND PURPOSE: Radiation therapy in patients with head and neck malignancies predisposes them to oral MATERIALS AND METHODS: This cross-sectional study was conducted from December 2018 to June 2019 at two referral radiotherapy centers in northern Iran. Yeast...

Cite
Kermani F, Sadeghian M, Shokohi T, et al. Molecular identification and antifungal susceptibility testing of . Curr Med Mycol. 2021;7(1):44-50doi: 10.18502/cmm.7.1.6242.
Kermani, F., Sadeghian, M., Shokohi, T., Hashemi, S., Moslemi, D., Davodian, S., Abastabar, M., Bandalizadeh, Z., Faeli, L., Seifi, Z., Fami Zaghrami, M., & Haghani, I. (2021). Molecular identification and antifungal susceptibility testing of . Current medical mycology, 7(1), 44-50. https://doi.org/10.18502/cmm.7.1.6242
Kermani, Firoozeh, et al. "Molecular identification and antifungal susceptibility testing of ." Current medical mycology vol. 7,1 (2021): 44-50. doi: https://doi.org/10.18502/cmm.7.1.6242
Kermani F, Sadeghian M, Shokohi T, Hashemi S, Moslemi D, Davodian S, Abastabar M, Bandalizadeh Z, Faeli L, Seifi Z, Fami Zaghrami M, Haghani I. Molecular identification and antifungal susceptibility testing of . Curr Med Mycol. 2021 Mar;7(1):44-50. doi: 10.18502/cmm.7.1.6242. PMID: 34553097; PMCID: PMC8443873.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 36 entries